Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.88 |
| ▸ | BLM | P54132 | 2/20 | 0.88 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.88 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.88 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.88 |
| ▸ | LMNA | P02545 | 1/20 | 0.88 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.88 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.88 |
| ▸ | TSHR | P16473 | 1/20 | 0.88 |
| ▸ | DRD1 | P21728 | 1/20 | 0.88 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.88 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.88 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.88 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.88 |
| ▸ | DRD3 | P35462 | 1/20 | 0.88 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.88 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.88 |
| ▸ | EYA2 | O00167 | 1/20 | 0.82 |
| ▸ | APP | P05067 | 1/20 | 0.82 |
| ▸ | ACE | P12821 | 1/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pentetic Acid SCHEMBL18917020 | 1.00 | TDP1 (0.88) | TDP1BLMPMP22KDM4EALOX15 | |
| Edetic Acid SCHEMBL4705343 | 0.97 | TDP1 (0.88) | TDP1BLMPMP22KDM4EALOX15 | |
| Edetic Acid SCHEMBL28357966 | 0.97 | TDP1 (0.88) | TDP1BLMPMP22KDM4EALOX15 | |
| Edetic Acid SCHEMBL66279 | 0.97 | TDP1 (0.88) | TDP1BLMPMP22KDM4EALOX15 | |
| Pentetic Acid SCHEMBL456025 | 0.97 | TDP1 (0.94) | TDP1BLMPMP22KDM4EALOX15 | |
| Edetic Acid SCHEMBL1091727 | 0.97 | TDP1 (0.88) | TDP1BLMPMP22KDM4EALOX15 | |
| Edetic Acid SCHEMBL2009701 | 0.97 | TDP1 (0.88) | TDP1BLMPMP22KDM4EALOX15 | |
| Edetic Acid SCHEMBL66280 | 0.97 | TDP1 (0.88) | TDP1BLMPMP22KDM4EALOX15 | |
| Edetic Acid SCHEMBL1685032 | 0.97 | TDP1 (0.88) | TDP1BLMPMP22KDM4EALOX15 | |
| Pentetic Acid SCHEMBL10890820 | 0.94 | TDP1 (0.88) | TDP1BLMPMP22KDM4EALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3080079-B1 | OXIDATION OF 2-MERCAPTOETHANOL | BASF SE (DE) | 2018-07-25 | — | — | EP | claimed |
| US-20160318860-A1 | OXIDATION OF 2-MERCAPTOETHANOL | BASF SE (DE) | 2016-11-03 | — | — | US | claimed |
| EP-3080079-B1 | OXIDATION OF 2-MERCAPTOETHANOL | BASF SE (DE) | 2018-07-25 | — | — | EP | disclosed |
| US-20160318860-A1 | OXIDATION OF 2-MERCAPTOETHANOL | BASF SE (DE) | 2016-11-03 | — | — | US | disclosed |
| US-8278243-B2 | Laser imaging | DATALASE LTD. (GB) | 2012-10-02 | — | — | US | disclosed |
| US-20100075848-A1 | Laser Imaging | DATALASE LTD. (GB) | 2010-03-25 | — | — | US | disclosed |
| US-7635730-B2 | neutralization of carboxyl containing unsaturated copolymer grafting of unsaturated anhydride in one step using organometallic chelating agent such as edta, tetrapotassium salt or mixed with alkali or alkaline or zinc metal oxide/ hydroxide/carbonates; materbatch; durability, scuff resistance; ionomers | BRIDGESTONE SPORTS CO., LTD. (JP) | 2009-12-22 | — | — | US | disclosed |
| US-20080161456-A1 | neutralization of carboxyl containing unsaturated copolymer grafting of unsaturated anhydride in one step using organometallic chelating agent such as edta, tetrapotassium salt or mixed with alkali or alkaline or zinc metal oxide/ hydroxide/carbonates; materbatch; durability, scuff resistance; ionomers | BRIDGESTONE SPORTS CO., LTD. (JP) | 2008-07-03 | — | — | US | disclosed |
| EP-1704057-A1 | LASER IMAGING | Sherwood Technology LTD. (GB) | 2006-09-27 | — | — | EP | disclosed |
| WO-2005068207-A1 | LASER IMAGING | DATALASE LTD. (GB) | 2005-07-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160318860-A1 | OXIDATION OF 2-MERCAPTOETHANOL | HAO2, GPX4, SQOR | TDP1 3992/4885BLM 647/4885PMP22 1297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.